Santiago Montes-Moreno

Summary

Country: Spain

Publications

  1. ncbi SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, Instituto de Formación e Investigación Marqués de Valdecilla, Santander, Spain
    Blood 121:643-7. 2013
  2. ncbi EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Spain
    Mod Pathol 25:968-82. 2012
  3. ncbi Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge
    Santiago Montes-Moreno
    Oncology Department, Hospital Ramon y Cajal, Madrid, Spain
    Leuk Lymphoma 53:185-94. 2012
  4. ncbi Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Centre CNIO, Madrid, Spain
    Blood 111:351-8. 2008
  5. ncbi Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
    Santiago Montes-Moreno
    Lymphoma Group, Molecular Pathology Programme Spanish National Cancer Research Centre, CNIO, Madrid, Spain
    Haematologica 95:1342-9. 2010
  6. ncbi Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features
    George Kanellis
    Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Haematologica 95:1122-9. 2010
  7. ncbi miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Blood 118:1034-40. 2011
  8. ncbi PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma
    Jose Francisco Garcia
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
    Haematologica 91:467-74. 2006
  9. ncbi Peripheral T-cell lymphoma with follicular T-cell markers
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1787-99. 2008
  10. ncbi PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma
    Syong H Nam-Cha
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1252-7. 2008

Collaborators

  • Lorena Maestre
  • Francisca I Camacho
  • Juan F Garcia
  • Luis Requena
  • Izaskun Trébol
  • Lorenzo Cerroni
  • Adonina Tardon
  • Francisco X Real
  • Nuria Malats
  • Josep Lloreta
  • Alfredo Carrato
  • Jose Luis Rodriguez-Peralto
  • Syong H Nam-Cha
  • Elias Campo
  • Eva Kimby
  • Marcos Malumbres
  • Yulei Shen
  • Teresa Marafioti
  • Renato Franco
  • Estella Matutes
  • Cherie Dunphy
  • Socorro Maria Rodriguez-Pinilla
  • Miguel A Piris
  • Miguel Angel Piris
  • Manuela Mollejo
  • Veronica Monsálvez
  • Lorena Di Lisio
  • Lydia Sanchez
  • Nerea Martinez
  • Socorro M Rodriguez-Pinilla
  • Giovanna Roncador
  • Pablo L Ortiz-Romero
  • Maciej J Czachorowski
  • María J Bueno
  • Rocio Ramos-Medina
  • Margarita Sanchez-Beato
  • Carlos Barrionuevo
  • Raquel Pajares
  • Jaime Montes
  • Sandro Casavilca
  • David G Pisano
  • George Kanellis
  • Juan C Cigudosa
  • Mohit Aggarwal
  • Socorro Maria Rodriguez Pinilla
  • Francisco J Martinez-Tello
  • Maria Isabel Longo
  • Ricardo Fernandez-de-Misa
  • Itziar Eraña Tomás
  • Yolanda Castro
  • Begoña Echevarría
  • Agueda Pulpillo
  • Manuel Almagro
  • Amparo Sevilla
  • Beatriz S Espiridión
  • Julio Alexander Díaz-Pérez
  • Maria E Rodriguez
  • Maria J Artiga
  • Gloria Camacho
  • Carlos Gonzalez
  • Maria Lozano
  • Alberto Puime Otín
  • Manolis Kogevinas
  • Miguel Piris-Villaespesa
  • Manuel M Morente
  • André F S Amaral
  • Adriana Lázaro
  • Ignacio Perez de Castro
  • Jose Fernandez-Piqueras
  • Maria Rodriguez-Pinilla
  • Marta Canamero
  • Javier Santos
  • Marta Gómez de Cedrón
  • Antonio Martinez
  • Gonzalo Gomez-Lopez
  • Ruth Sánchez-Martínez
  • María de los Ángeles
  • Manuel Guerrero
  • Mayer Zaharia
  • Patricia Algara
  • Andrew Wotherspoon
  • Eduardo Zevallos-Giampietri
  • Carlos Montalban
  • Marco T Martinez
  • Francisco Bravo
  • Patrocinio Algara
  • Miguel Angel Limeres-González
  • Rocio Juarez
  • Jeronimo Forteza
  • Antonia Rodriguez

Detail Information

Publications23

  1. ncbi SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, Instituto de Formación e Investigación Marqués de Valdecilla, Santander, Spain
    Blood 121:643-7. 2013
    ..We conclude that SPIB expression can be used as a tool for diagnosing BPDC neoplasms, but it needs to be tested in conjunction with the growing arsenal of markers for human plasmacytoid dendritic cells...
  2. ncbi EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
    Santiago Montes-Moreno
    Pathology Department, Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Spain
    Mod Pathol 25:968-82. 2012
    ..Thus, alternative therapies, based on the tumor biology, need to be tested in patients with EBV-positive diffuse large B-cell lymphoma of the elderly...
  3. ncbi Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge
    Santiago Montes-Moreno
    Oncology Department, Hospital Ramon y Cajal, Madrid, Spain
    Leuk Lymphoma 53:185-94. 2012
    ....
  4. ncbi Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Centre CNIO, Madrid, Spain
    Blood 111:351-8. 2008
    ..The results of RNA and protein expression should prompt further investigation into the role of Gcet1 in regulating B-cell survival...
  5. ncbi Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
    Santiago Montes-Moreno
    Lymphoma Group, Molecular Pathology Programme Spanish National Cancer Research Centre, CNIO, Madrid, Spain
    Haematologica 95:1342-9. 2010
    ..Plasmablastic lymphoma has recently come to be considered a distinct entity among mature B cell neoplasms, although the limits with diffuse large B-cell lymphoma (DLBCL) need to be more accurately defined...
  6. ncbi Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features
    George Kanellis
    Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Haematologica 95:1122-9. 2010
    ..Additional work is required to review this entity and establish its diagnostic features...
  7. ncbi miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Blood 118:1034-40. 2011
    ..This information improves upon IPI-based predictions and identifies a subgroup of candidate patients for alternative therapeutic regimens...
  8. ncbi PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma
    Jose Francisco Garcia
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
    Haematologica 91:467-74. 2006
    ..The positive regulatory domain I (PRDM1) protein or BLIMP-1, belonging to the PRDM gene family of transcriptional repressors, is a key regulator of terminal differentiation in B-lymphocytes and is critical for plasma cell differentiation...
  9. ncbi Peripheral T-cell lymphoma with follicular T-cell markers
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1787-99. 2008
    ..The aim of this study was to establish whether other PTCL subgroups also express TFH cell markers...
  10. ncbi PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma
    Syong H Nam-Cha
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1252-7. 2008
    ..The standard T/HRBCL cases lack follicular T-cell rosettes, whereas most of the borderline cases between the 2 entities have follicular T-cell rosettes, thus suggesting a closer relation with NLPHL...
  11. ncbi The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas
    Lorena Di Lisio
    Hospital Universitario Marqués de Valdecilla HUMV Instituto de Formación e Investigación Marqués de Valdecilla IFIMAV, Santander, Spain
    Blood 120:1782-90. 2012
    ..They identify miRNAs that could be used for diagnosis, prognosis, or prediction of response to specific therapies...
  12. ncbi Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases
    Socorro M Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Histopathology 59:1183-93. 2011
    ..The aim of this study was to characterize six cases of paediatric EBV-positive peripheral T-cell lymphoma with distinct features...
  13. ncbi Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues
    Rocio Ramos-Medina
    Monoclonal Antibodies Unit, Biotechnology Programme, Spanish National Cancer Research Centre, Madrid, Spain
    Immunol Lett 134:150-6. 2011
    ....
  14. ncbi EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre, CNIO, Madrid, Spain
    Am J Surg Pathol 34:1773-82. 2010
    ....
  15. ncbi TCR-γ expression in primary cutaneous T-cell lymphomas
    Socorro Maria Rodriguez-Pinilla
    CNIO Lymphoma Group, Fundacion Jimenez Diaz, Madrid, Spain
    Am J Surg Pathol 37:375-84. 2013
    ..Moreover, its expression does not seem to be associated with bad prognosis by itself, as it can be found in cases with good and bad outcomes...
  16. ncbi Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers
    Socorro Maria Rodriguez Pinilla
    Lymphoma Group, Molecular Pathology Programme, Monoclonal Antibody Unit, Biotechnology Programme, Spanish National Cancer Research Centre, Hospital Universitario 12 de Octubre, Madrid, Spain
    Am J Surg Pathol 33:81-90. 2009
    ..Moreover, these findings suggest that B-cell stimulation by FTH could also take place in some cutaneous T-cell lymphomas...
  17. ncbi TCL1A expression delineates biological and clinical variability in B-cell lymphoma
    Mohit Aggarwal
    Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Mod Pathol 22:206-15. 2009
    ....
  18. ncbi Expression pattern of XBP1(S) in human B-cell lymphomas
    Lorena Maestre
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
    Haematologica 94:419-22. 2009
    ..Furthermore, our results establish a direct and practical means of assessing ER stress in human tumors...
  19. ncbi Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway
    María J Bueno
    Cell Division and Cancer Group, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Blood 117:6255-66. 2011
    ..Some of these Myc-targeting miRNAs are repressed by Myc, suggesting that these tumors are a consequence of the unbalanced activity of Myc versus miRNAs...
  20. ncbi Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases
    Manuela Mollejo
    Pathology Department, Hospital Virgen de la Salud, Toledo, Spain
    Am J Surg Pathol 33:730-8. 2009
    ..Recognition of the distinct nature of these tumors should facilitate appropriate studies for determining the best therapy for such cases...
  21. ncbi MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma
    Veronica Monsálvez
    Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Mod Pathol 26:171-81. 2013
    ..05). In summary, miRNA expression analysis can be used as a tool for diagnosis and outcome prognosis in indolent primary cutaneous B-cell lymphoma...
  22. ncbi Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis
    Maciej J Czachorowski
    Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    PLoS ONE 7:e45025. 2012
    ..The meta-analysis confirmed these results. We did not find evidence that COX2 expression is an independent prognostic marker of recurrence, progression or survival in patients with UCB...
  23. ncbi Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: a previously undescribed association of findings
    Francisco J Martinez-Tello
    Departamento de Anatomia Patologica, Hospital Universitario 12 de Octubre, Carretera de Andalucía Km 5400, 28041, Madrid, Spain
    Skeletal Radiol 34:793-8. 2005
    ..We have been unable to find a similar case in the world literature. We discuss our findings in relationship with a number of syndromes that present clinical, radiological or pathological similarities...